Filter posts

Synthetic Biology: The Sword in the Stone to Defeat Devastating Diseases

On July 17th, 2014 the House held a hearing titled: Subcommittee on Research and Technology …

What International Trade Agreements Have to Do with Innovation

Innovation is not just the life-blood of the biotech industry, it is the very premise …

Supreme Court Enunciates New Indefiniteness Standard

The Supreme Court has once again reversed a decision by the Federal Circuit, in this …

Patent Reform Legislation Off The Table For Now

If the mainstream media is to be believed, the patent system is broken.  This notion …

Supreme Court Decision on Web Content Delivery to Impact Biotech Patents

Earlier this month, in Limelight Networks, Inc. v. Akamai Technologies, Inc., the Supreme Court issued …

IP at the 2014 BIO International Convention

Securing and maintaining intellectual property protection for the next generation of biotech innovation faces new …

Nautilus v. Biosig, Baxter v. Fresenius and Limelight v. Akamai

BIO weighed in on three Supreme Court cases in the last few months whose outcome …

Special 301: BIO Highlights Challenges in India

BIO recently testified before the U.S. government on the intellectual property challenges our members face …

Report Shows World's Weakest IP Environments

There is clear link between a country’s rate of economic development and the strength of …

Innovation Act Passed By House

The Innovation Act (H.R. 3309), which is intended to reduce frivolous patent-related litigation, was passed …